Anthem Inc (ANTM) Gets a Buy Rating from Barclays

By Carrie Williams

In a report released today, Steven Valiquette from Barclays maintained a Buy rating on Anthem Inc (ANTMResearch Report), with a price target of $316. The company’s shares opened today at $243.40.

According to TipRanks.com, Valiquette is a 3-star analyst with an average return of 2.7% and a 45.0% success rate. Valiquette covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Walgreens Boots Alliance, and Patterson Companies Inc.

Currently, the analyst consensus on Anthem Inc is a Strong Buy with an average price target of $352.50.

See today’s analyst top recommended stocks >>

Anthem Inc’s market cap is currently $63.1B and has a P/E ratio of 17.27. The company has a Price to Book ratio of 2.21.

Based on the recent corporate insider activity of 35 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Anthem, Inc. provides life, hospital and medical insurance plans. It offers a broad spectrum of network-based managed care health benefit plans to the large and small employer, individual, Medicaid, and Medicare markets. The company operates through the following segments: Commercial & Specialty Business, Government Business and Other.